
American Fusion received Texas certification for its Texatron fusion engine, clearing the way for testing at Texas Tech. The OTC developer now faces a long road to commercialisation.
FORT WORTH, Texas–American Fusion Inc. (OTC: AMFN) said it received state certification covering all twelve registered models of its Texatron Fusion Engine, clearing the way for a testing program at Texas Tech University. Executive Chairman Brent Nelson disclosed the milestone in an interview with SmallCapVoice.com.
The certification, issued by the Texas Department of State Health Services, covers units ranging from 500 kilowatts to a gigawatt-scale system. Nelson called it a "green light to move forward." The company intends to begin testing in the coming days at Texas Tech, where teams are coordinating logistics and data collection.
Initial objectives include validating fusion reactions within the Texatron platform and collecting performance metrics on plasma behavior and system operation. The testing program will progress through a series of unspecified milestones.
American Fusion also said Chief Technical Officer Dr. John Brandenburg will present the company's technology at an upcoming particle physics conference. Nelson framed third-party scientific validation as a critical step toward credibility in the fusion space.
On the commercial side, the company is developing 5-megawatt, 10-megawatt and 20-megawatt configurations and recently appointed a Chief Revenue Officer to target government, military and commercial customers. American Fusion said it is pursuing an extensive patent filing strategy and launched an AI-powered investor communications platform.
The press release follows the typical pattern for an OTC microcap developer: a series of forward-looking claims without revenue or operational history. The certification is a regulatory box-check, not a scientific proof. The real test–whether the Texatron can produce net energy–remains ahead.
For the rest of 2026, American Fusion listed primary objectives including completing the testing program, filing additional patents, securing financing, and working toward an SEC registration and potential exchange uplisting. None of those steps guarantee commercialization.
The next catalyst is the testing data from Texas Tech and the feedback from the physics conference. Until independent results surface, the stock trades on narrative alone.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.